Neurology

Medicine & Life Sciences

1. Stroke 100%
2. Alzheimer Disease 93%
3. Parkinsonian Disorders 54%
4. Mutation 53%
5. Frontotemporal Dementia 52%
6. Genes 37%
7. Dementia 36%
8. Brain 35%
9. Frontotemporal Lobar Degeneration 35%
10. Amyotrophic Lateral Sclerosis 32%
11. Genome-Wide Association Study 29%
12. Progressive Supranuclear Palsy 28%
13. Pathology 25%
14. Therapeutics 23%
15. Cerebral Hemorrhage 23%
16. Headache 22%
17. Cognitive Dysfunction 20%
18. Single Nucleotide Polymorphism 20%
19. Amyloid 19%
20. Synucleins 19%
21. Cluster Headache 19%
22. Atrophy 18%
23. Neurodegenerative Diseases 18%
24. Phenotype 17%
25. Seizures 17%
26. Carotid Arteries 17%
27. Tissue Plasminogen Activator 16%
28. Epilepsy 16%
29. Biomarkers 16%
30. Age of Onset 16%
31. African Americans 15%
32. Tremor 15%
33. Glioblastoma 15%
34. Essential Tremor 15%
35. Frontotemporal Dementia With Motor Neuron Disease 15%
36. Progranulins 15%
37. Multiple System Atrophy 15%
38. Meta-Analysis 15%
39. Genome 14%
40. Migraine Disorders 14%
41. Brain Neoplasms 14%
42. White Matter 13%
43. Chromosomes, Human, Pair 17 13%
44. Clinical Trials 12%
45. Alleles 12%
46. National Institute of Neurological Disorders and Stroke (U.S.) 12%
47. Substantia Nigra 12%
48. Glioma 12%
49. Population 12%
50. Odds Ratio 12%
51. Neuroimaging 12%
52. Leucine 12%
53. Levodopa 12%
54. Microtubule-Associated Proteins 11%
55. Haplotypes 11%
56. Lewy Bodies 11%
57. Apolipoproteins E 11%
58. Phosphotransferases 11%
59. Normal Pressure Hydrocephalus 11%
60. Cerebrospinal Fluid 11%
61. Autopsy 10%
62. Genotype 10%
63. Perry Syndrome 10%
64. Electroencephalography 10%
65. Neoplasms 10%
66. Nervous System 10%
67. Infarction 10%
68. Endarterectomy 10%
69. Mental Status and Dementia Tests 9%
70. Magnetic Resonance Imaging 9%
71. Tauopathies 9%
72. Proteins 9%
73. Deep Brain Stimulation 9%
74. Dystonia 9%
75. Exons 9%
76. Leukoencephalopathies 9%
77. Colony-Stimulating Factor Receptors 9%
78. Placebos 9%
79. Temporal Lobe 9%
80. Survival 8%
81. Chromosomes, Human, Pair 9 8%
82. Headache Disorders 8%
83. Inborn Genetic Diseases 8%
84. Mortality 8%
85. Safety 8%
86. Memory 7%
87. Randomized Controlled Trials 7%
88. Subarachnoid Hemorrhage 7%
89. Trigeminal Neuralgia 7%
90. Cerebral Infarction 7%
91. Temozolomide 7%
92. Blood Pressure 7%
93. Cognition 7%
94. Macrophage Colony-Stimulating Factor 7%
95. Positron-Emission Tomography 7%